In the MediaHome› Company Overview› News & Events› In the MediaMay 18, 2022 iCAD announces new research supporting ProFound AI for DBT Read MoreMay 16, 2022 New Research Finds iCAD’s ProFound AI Risk for Digital Breast Tomosynthesis is 2.4x More Accurate than Traditional Lifetime Risk Models Read MoreMay 12, 2022 Digital Breast Tomosynthesis Tool Can Help Predict Breast Cancer Read MoreMarch 23, 2022 iCAD Accelerates Cancer Detection and Treatment with NVIDIA AI Enterprise Stack Read MoreDecember 2, 2021 More research, transparency needed for combining AI with DBT Read MoreDecember 1, 2021 Arterys and iCAD sign distribution deal Read MoreDecember 1, 2021 Arterys and iCAD sign global distribution agreement Read MoreNovember 30, 2021 Arterys and iCAD join forces to roll out breast health AI solutions worldwide Read MoreNovember 29, 2021 AI Enterprise Helps Researchers, Hospitals Targeting Cancer Hit the Mark Read MoreNovember 29, 2021 iCAD announces data on ProFound AI at RSNA 2021 Read MoreOctober 28, 2021 Innovation in Breast Cancer Screening Read MoreOctober 27, 2021 Why Breast Cancer Risk Assessment is Key to Improving Outcomes Read More Previous 1 … 7 8 9 10 11 … 23 Next
